human SERPINA9 protein

RefSeq NM_175739

Also Known As:

SERPINA9 protein, human; GCET1 protein, human; centerin; germinal center B cell-expressed transcript 1 protein, human; serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9, human

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Serpins: 906
    - human SERPINA9 protein: 7
  - Neoplasm Proteins: 2
    - human SERPINA9 protein: 7
- Peptides: 82426
  - Serpins: 906
    - human SERPINA9 protein: 7
Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Molecular Mechanisms of Pharmacological Action: 24
    - Enzyme Inhibitors: 1659
      - Protease Inhibitors: 6291
        Serine Proteinase Inhibitors: 1371
        Serpins: 906
        human SERPINA9 protein: 7

Experts

1.	Coughlin, Paul B: 2 articles (07/2008 - 08/2007)
2.	Paterson, Melinda A: 2 articles (07/2008 - 08/2007)
3.	Fujita, Hiromu: 1 article (01/2022)
4.	Higashi, Takahiro: 1 article (01/2022)
5.	Iijima, Katsunori: 1 article (01/2022)
6.	Imai, Kazuhiro: 1 article (01/2022)
7.	Koizumi, Shigeto: 1 article (01/2022)
8.	Maeda, Eri: 1 article (01/2022)
9.	Minamiya, Yoshihiro: 1 article (01/2022)
10.	Motoyama, Satoru: 1 article (01/2022)

Related Diseases

1.	Primary hyperoxaluria type 1 01/01/2021 - "This study aimed to investigate results of combined liver and kidney, sequential, and preemptive livertransplantin patients with primary hyperoxaluria type 1. In this cohort study, we followed patients with primary hyperoxaluria type 1 who underwent liver transplant at our centerin Shiraz, Iran. "
2.	Neoplasms (Cancer) 01/01/2022 - "We retrieved the 2008 to 2011 data from the National Database of Hospital-based Cancer Registries from the National Cancer Centerin Japan, divided the patients into a ≥75 group (75-79 years; n = 2935) and a ≥80 group (80 years or older; n = 2131), and then compared the patient backgrounds and survival curves. " 07/01/2008 - "Centerin (SERPINA9/GCET1) is a protease inhibitor with expression restricted to germinal center B cells and lymphoid malignancies with germinal center B-cell maturation. " 08/01/2007 - "Centerin [SERPINA9/GCET1 (germinal centre B-cell-expressed transcript 1)] is a serpin (serine protease inhibitor) whose expression is restricted to germinal centre B-cells and lymphoid malignancies with germinal centre B-cell maturation. "
3.	B-Cell Lymphoma (Lymphoma, B Cell) 07/01/2008 - "In addition, 14 (47%) of 30 diffuse large B-cell lymphomas were positive for centerin, which correlated most closely with CD10 expression. " 07/01/2008 - "Expression of the centerin gene transcript, along with bcl-6 and GCET2/HGAL, constitutes a molecular signature associated with a good prognosis in diffuse large B-cell lymphomas. " 08/01/2007 - "Expression of centerin, together with bcl-6 and GCET2, constitutes a germinal centre B-cell signature, which is associated with a good prognosis in diffuse large B-cell lymphomas, but the molecular basis for this remains to be elucidated. " 07/01/2008 - "Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas."
4.	Lymphoma (Lymphomas) 07/01/2008 - "Immunohistochemical expression of centerin further defines the germinal center cell origin of a subgroup of lymphomas." 01/01/2008 - "Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas."
5.	Burkitt Lymphoma (Burkitt's Lymphoma) 07/01/2008 - "Centerin expression was demonstrated in Burkitt lymphoma Raji cells. " 10/01/2000 - "Transcription of centerin is highly restricted to GC B cells and their malignant counterparts, Burkitt's lymphoma lines. "

Related Drugs and Biologics

1.	Serpins
2.	Serine Proteinase Inhibitors (Serine Protease Inhibitors)
3.	Proteins (Proteins, Gene)
4.	Protease Inhibitors (Protease Inhibitor)

Related Therapies and Procedures

1.	Liver Transplantation